Biosimilar Tipping Point: Five Questions For Henlius CEO

 
• By Brian Yang
  
China flag with arrow graph going up showing strong economy and shares rise. Profit and success. Isolated vector illustration.
CEO Of China's Henlius Talks Biosimilar Development And Emerging Markets Strategy • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products